Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Clinical trial NCT00305084 · COMPLETED
Trial details
- NCT number
- NCT00305084
- Sponsor
- AGC Biologics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-28
- Primary completion
- 2007-05-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.